Market Overview

India Sorbitol market is expected to grow at CAGR of 5.9% during the forecast period and reach USD 219.40 million by 2030. Sorbitol is mainly obtained from corn, algae, fruits, and berries. It is made by catalytic hydrogenation of sucrose. Sorbitol is mainly used as a sweetener, moisturizer, fragrance and diuretic in various applications such as foods and beverages, pharmaceuticals, cosmetics and personal care. Sorbitol is a low-calorie sugar substitute used in many products such as candies, chewing gum, ice cream, baked goods, cosmetics, toothpaste, personal care products and pharmaceuticals.

Increasing consumer awareness of the benefits derived from natural ingredients is expected to drive demand. Organic personal care and cosmetic products are expected to grow in popularity due to health and safety reasons. Increasing demand for low-calorie artificial sweeteners, especially among diabetic patients, is expected to fuel sorbitol market growth. The market is expected to grow significantly during the forecast period due to increased use of food and beverages in diabetes and diet. Increasing demand for products as sugar substitutes for consumer goods should also stimulate demand for products in the coming years. Because sorbitol is slower to metabolize than other sugar alcohols, it is increasingly being used in oral care products to prevent tooth problems such as tooth decay and tooth decay. These benefits are expected to drive industry growth over the forecast period. In addition, lower production and labor costs tend to move manufacturing capacity to the Asia-Pacific region, especially India lowering the cost of sorbitol and increasing demand from non-food applications.

Market Segmentation

By application, the India sorbitol market is segmented into food & beverage, personal care, pharmaceutical & nutraceuticals, and others. Increasing demand for sorbitol as a sweetener is expected to majorly drive the market growth during the forecast period.

Regional Analysis

Based on region, the Indian sorbitol market is bifurcated into North, East, South, West, North-East, and Central India.

In India, sorbitol is mainly produced only as a 70% solution and the operating capacity is nearly 125900 tons per annum. South India holds the major portion of the Indian sorbitol market. Because of favorable government initiatives in India are expected to drive the demand in the market. Additionally, the increasing economy along with the increasing middle-class population in India is propelling market growth in the years to come. The o rising demand for sorbitol, is =driven by its increased use in the cosmetic & personal care and food & beverages industries across India. Moreover, the increase in purchasing power parity of consumers also propels the demand for sorbitol-based products, such as confections, bakery, dairy, and other food products such as cereals and desserts.

Major Players

Some of the players operating in the India Sorbitol market are Gujarat Ambuja Exports Limited, Pruthvi’s Foods Private Limited, Cargill Incorporated, Roquette Freres, and Archer Daniels Midland Company among others.

COVID 19 Impacts

We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY
1.1.1 INDIA SORBITOL MARKET, BY TYPE
1.1.2 INDIA SORBITOL MARKET, BY APPLICATION
2 MARKET INTRODUCTION
2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 MARKET STRUCTURE
3 RESEARCH METHODOLOGY
3.1 RESEARCH PROCESS
3.2 PRIMARY RESEARCH
3.3 SECONDARY RESEARCH
3.4 MARKET SIZE ESTIMATION
3.5 TOP DOWN & BOTTOM UP APPROACH
3.6 FORECAST MODEL
3.7 LIST OF ASSUMPTIONS
4 MARKET DYNAMICS
4.1 INTRODUCTION
4.2 DRIVERS
4.2.1 INCREASING DEMAND FOR LOW SUGAR AND LOW-CALORIES PRODUCTS
4.2.2 GROWING USE OF SORBITOL IN CONFECTIONARY AND CHOCOLATES PRODUCTS
4.2.3 DRIVERS IMPACT ANALYSIS
4.3 RESTRAINTS
4.3.1 LACK OF QUALITY STANDARDS:
4.3.2 RESTRAINTS IMPACT ANALYSIS
4.4 OPPORTUNITIES
4.4.1 INITIATIVES TAKEN BY GOVERNMENTS AND INSTITUTIONS TO PROMOTE A HEALTHY DIET
4.5 IMPACT OF COVID-19 ON THE INDIA SORBITOL MARKET
4.5.1 IMPACT ON SUPPLY CHAIN OF SORBITOL
4.5.2 IMPACT ON APPLICATION INDUSTRY
4.5.3 IMPACT ON MARKET DEMAND AND PRODUCTION OF SORBITOL
5 MARKET FACTOR ANALYSIS
5.1 SUPPLY/VALUE CHAIN ANALYSIS
5.1.1 RAW MATERIAL SUPPLIERS
5.1.2 MANUFACTURERS
5.1.3 DISTRIBUTION CHANNEL
5.2 PORTER’S FIVE FORCES MODEL
5.2.1 THREAT OF NEW ENTRANTS
5.2.2 BARGAINING POWER OF SUPPLIERS
5.2.3 BARGAINING POWER OF BUYERS
5.2.4 THREAT OF SUBSTITUTES
5.2.5 INTENSITY OF RIVALRY
6 INDIA SORBITOL MARKET, BY TYPE
6.1 OVERVIEW
6.2 LIQUID SORBITOL
6.3 POWDER/CRYSTAL SORBITOL
7 INDIA SORBITOL MARKET, BY APPLICATION
7.1 OVERVIEW
7.2 FOOD & BEVERAGES
7.3 PHARMACEUTICALS & NUTRACEUTICALS
7.4 PERSONAL CARE
7.5 OTHERS
8 INDIA SORBITOL MARKET, BY REGION
8.1 OVERVIEW
8.2 NORTH
8.3 EAST
8.4 SOUTH
8.5 WEST
8.6 NORTH-EAST
8.7 CENTRAL
9 COMPETITIVE LANDSCAPE
9.1 COMPETITIVE OVERVIEW
9.2 INDIA SORBITOL MARKET: COMPANY SHARE ANALYSIS
10 COMPANY PROFILES
10.1 ARCHER DANIELS MIDLAND COMPANY
10.1.1 COMPANY OVERVIEW
10.1.2 FINANCIAL OVERVIEW
10.1.3 PRODUCTS OFFERED
10.1.4 KEY DEVELOPMENTS
10.1.5 SWOT ANALYSIS
10.1.6 KEY STRATEGIES
10.2 CARGILL INCORPORATED
10.2.1 COMPANY OVERVIEW
10.2.2 FINANCIAL OVERVIEW
10.2.3 PRODUCTS OFFERED
10.2.4 KEY DEVELOPMENTS
10.2.5 SWOT ANALYSIS
10.2.6 KEY STRATEGIES
10.3 ROQUETTE FRERES
10.3.1 COMPANY OVERVIEW
10.3.2 FINANCIAL OVERVIEW
10.3.3 PRODUCTS OFFERED
10.3.4 KEY DEVELOPMENTS
10.3.5 SWOT ANALYSIS
10.3.6 KEY STRATEGIES
10.4 INGREDION INCORPORATED
10.4.1 COMPANY OVERVIEW
10.4.2 FINANCIAL OVERVIEW
10.4.3 PRODUCTS OFFERED
10.4.4 KEY DEVELOPMENTS
10.4.5 SWOT ANALYSIS
10.4.6 KEY STRATEGIES
10.5 DUPONT
10.5.1 COMPANY OVERVIEW
10.5.2 FINANCIAL OVERVIEW
10.5.3 PRODUCTS OFFERED
10.5.4 KEY DEVELOPMENTS
10.5.5 SWOT ANALYSIS
10.5.6 KEY STRATEGIES
10.6 GULSHAN POLYOLS LTD
10.6.1 COMPANY OVERVIEW
10.6.2 FINANCIAL OVERVIEW
10.6.3 PRODUCTS OFFERED
10.6.4 KEY DEVELOPMENTS
10.6.5 SWOT ANALYSIS
10.6.6 KEY STRATEGIES
10.7 GUJARAT AMBUJA EXPORTS LIMITED
10.7.1 COMPANY OVERVIEW
10.7.2 FINANCIAL OVERVIEW
10.7.3 PRODUCTS OFFERED
10.7.4 KEY DEVELOPMENTS
10.7.5 SWOT ANALYSIS
10.7.6 KEY STRATEGIES
10.8 KASYAP SWEETNERS LTD
10.8.1 COMPANY OVERVIEW
10.8.2 FINANCIAL OVERVIEW
10.8.3 PRODUCTS OFFERED
10.8.4 KEY DEVELOPMENTS
10.8.5 SWOT ANALYSIS
10.8.6 KEY STRATEGIES
10.9 RAM SHREE CHEMICALS
10.9.1 COMPANY OVERVIEW
10.9.2 FINANCIAL OVERVIEW
10.9.3 PRODUCTS OFFERED
10.9.4 KEY DEVELOPMENTS
10.9.5 SWOT ANALYSIS
10.9.6 KEY STRATEGIES
10.10 PRUTHVI’S FOODS PRIVATE LIMITED
10.10.1 COMPANY OVERVIEW
10.10.2 FINANCIAL OVERVIEW
10.10.3 PRODUCTS OFFERED
10.10.4 KEY DEVELOPMENTS
10.10.5 SWOT ANALYSIS
10.10.6 KEY STRATEGIES
11 APPENDIX
11.1 REFERENCES
11.2 RELATED REPORTS

The post India Sorbitol Market Research Report Forecast to 2030 first appeared on CRI Report.

Market Overview

Strategic initiatives by major players and development of aluminum wiring harness will spur market growth. The North America EV Wiring Harness Market is projected to grow at a CAGR of 30.21% over the forecast period, 2021 – 2027.

A wiring harness is a structured set of wires, terminals and connectors which run throughout the vehicle and relay information and electric power. The wiring harness plays a major role in connecting a wide variety of components in an automotive. It is used for transmitting power and information throughout the vehicle.

A harness secures wires and cables against the adverse effects caused by abrasions, moisture, and vibrations in the car.

The North America EV wiring harness market is driven by factors such as strategic initiatives by major players and development of aluminum wiring harness. However, over-heating or short circuit of the wiring harness is expected to restrain market growth. Growing use of vehicle electronic systems are expected to create opportunities for the market players.

Market Segmentation

This section analyses the market size and growth of the EV wiring harness market in North America, along with a split between high voltage and low voltage cables. Besides, EV wiring harness analysis by material and type of flame retardants are covered in this section.

The rapidly growing EV market is reliant upon a network of cables to support charging. High voltage cables find applications in charging EVs, battery harness and traction harness. Domestic and global players would look to the EV charge connectors and cables of high voltages for vehicle connections.

Low voltage cables include automotive cables for the electric vehicle itself, such as cables for low-tension electrical wiring in starting, lighting, signalling, and instrument panel circuits. The low voltage EV wiring harnesses are suitable for the connections inside the vehicle. The applications involved lighting, motor control, audio harness, HVAC, and door harness.

Such low voltage EV cables are engineered to meet UL and SAE standards and offer superior durability for wiring inside the vehicle. The XLPE segment accounted for the largest market share in 2020, with a market value of USD 654.9 million; it is expected to register a CAGR of 27.9% during the forecast period. The Silicone Rubber segment was valued at USD 229.0 million; it is projected to exhibit a CAGR of 35.6%.

Regional analysis

The North America EV Wiring Harness Market has been segmented, based on country, into US, Canada, Mexico.

Major Players

Sumitomo Electric Industries Ltd (Japan), Furukawa Electric Co. Ltd (Japan), Yazaki Corporation (Japan), and LEONI AG Germany (Germany).

The post North America EV Wiring Harness Market Research Report Forecast to 2027 first appeared on CRI Report.

Market Overview
The growth of the Europe home blood capillary diagnostics kits market is attributed due to the increase in the number of product approvals and the growing geriatric population. Other factors such as the increase in chronic and infectious diseases are fuelling the Europe home blood capillary diagnostics kits market.

However, concerns regarding the risks associated with the process might hamper the market growth to some extent.
Capillary blood sampling, or drawing blood from a puncture on a finger, heel, or earlobe, is becoming more popular in medicine. It has various advantages over venous blood collection, such as being less intrusive, requiring less blood volume, and being rapid and simple to conduct.

An increase in the number of product approvals and an increase in chronic and infectious diseases are expected to be some of the major factors driving the market growth during the forecast period. Another factor that supplements the market growth is the increasing geriatric population in Europe. However, associated risks of capillary blood collection may hinder the market growth.

Market Segmentation
Based on component type, the Europe home blood capillary diagnostics kits market has been segmented into micro collection tubes, lancets, and others. The micro collection tubes segment is expected to be the largest and fastest-growing market throughout the study period. It is estimated to hold a market share of 45.58% in 2020, exhibiting a CAGR of 5.99% during the assessment period

Based on application, the Europe home blood capillary diagnostics kits market has been categorized into whole blood tests, plasma/serum protein tests, Comprehensive Metabolite Panel (CMP), liver panel/liver profile/Liver Function Tests (LFTs), blood glucose monitoring, blood gases testing and others. The blood glucose monitoring segment is expected to be the largest segment registering a market share of 27.1% in 2020. The blood glucose monitoring test is also the fastest-growing segment with a CAGR of 6.92% owing to factors such as the rising population of diabetes patients across Europe.

Regional Market
The Europe home blood capillary diagnostics kits market is segmented into Germany, France, the UK, Italy, Ireland, Netherlands, The Nordics, Spain, and the rest of Europe. Germany held the largest market share of USD 49.02 million in 2020 and is anticipated to dominate the Europe home blood capillary diagnostics kit market during the forecast period.

Blood can either be collected on filter paper or in capillary blood collection tubes with a serum separator additive. The Europe home blood capillary diagnostics kit market is anticipated to increase with a surge in the number of infectious diseases. Europe comprises a large population prone to infectious diseases. Chlamydia infection, campylobacteriosis, salmonellosis, gonorrhea, and tuberculosis are some of the most reported infectious diseases in Europe.

Major Players
The key competitors in the Europe Home Blood Capillary Diagnosis market are Neoteryx, LLC (Canada), Tasso Inc. (US), Becton, Dickinson, and Company, Hemaxis, Eldon Biologics A/S, Cerascreen, Seventh Sense Biosystems, Nature’s Way Products LLC, and others.

The post Europe Home Blood Capillary Diagnostics Kits Market 2027 first appeared on CRI Report.

Market insights:
Hospitals are the major stakeholders in India’s healthcare ecosystem. About 70% of the rural population and 80% of the urban residents rely on private hospitals. High disposable income, rise in population, and changes in disease profiles are driving the expansion of the market. Furthermore, the Ayushman Bharat initiative has strengthened the healthcare system, from primary to tertiary care.

The private hospital sector was valued at INR 9,995.06 Bn in FY 2021. It is expected to reach INR 25,429.49 Bn by FY 2027, expanding at a compound annual growth rate (CAGR) of ~20.53% during the FY 2021 ─ FY 2027 period

Segment insights:
It has three segments – self-pay, government payer, and corporate insurer. Initially at the beginning of 2020, the self-pay segment dominated the market, followed by government payer. However, owing to the expansion of insurance coverage by both government and corporate insurers, the corporate insurer segment is anticipated to experience noticeable growth.

Increase in purchasing power, growing demand for quality healthcare, technological advancements, and development of private hospital networks have fueled the growth of corporate medical insurance. It ensures patients’ entitlement to accidental hospitalization, COVID-19 insurance, daily hospital benefits, critical illness cover, and maternity coverage.

Impact of COVID-19:
The second wave of COVID-19 affected the private hospital sector because patient footfall, both, domestic and international, declined. High infection rates and lockdowns compelled hospitals to pause non-emergency, and outdoor patient department (OPD) and indoor patient department (IPD) services. Medical tourism also declined due to travel restrictions.

Despite the initial dip in footfall, signs of recovery in patients and relaxed lockdown norms by the end of July 2021 marked an increase in hospital occupancy rate. Although the initial setback caused a nationwide crisis in India’s primary healthcare, key changes in the sector such as flexibility in operations, improved health insurance, and cost-effective medical tourism will strengthen the private hospital sector.

Related reports:

Hospital Outsourcing market : Global Analysis of Market Size, Share & Trends for 2019 – 2020 and Forecasts to 2030

Remote Patient Monitoring (RPM) Market: By Type (Heart Monitors, Breath Monitors, Hematology Monitors, Multi-parameter Monitors, and Other); By Application (Cancer Treatment, Cardiovascular Diseases, Diabetes Treatment, Sleep Disorder, Weight Management and Fitness Monitoring and Other); By End User (Home Care Settings, Hospital/Clinics and Other); and Region- Global Analysis by Market Size, Share & Trends for 2014- 2020 and Forecasts to 2030

Global Personal mobility device market By Product Type (Wheelchair, Walking Aids, Scooters and Others); By Application (Power and Manual); By End Users (Homecare Setting, Hospitals & Clinics and Others); and Region- Analysis of Market Size, Share & Trends for 2019- 2020 and Forecasts to 2030

The post Private Hospital Sector in India 2021 first appeared on CRI Report.

Market insights:
The OTT market can be segmented into video and audio OTT. The video OTT market in India was valued at INR 86.98 Bn in FY 2020. It is expected to expand at a compound annual growth rate (CAGR) of ~30.73% during the FY 2022 – FY 2026 period. Original premium content, especially in regional language, is one of the biggest growth drivers and differentiators, because several OTT platforms are vying for consumers’ attention. The audio OTT market was valued at INR 44.21 Bn in FY 2021 and is expected to reach INR 99.98 Bn by FY 2026, expanding at a CAGR of ~19.14% during the FY 2022 – FY 2026 period. An increased focus on launching original music is expected to help these platforms acquire new users, which will ultimately result in the expansion of the overall user base.

Segment insights:

The video OTT can be segmented on the basis of revenue models. The major revenue models of video OTT are advertising video on demand (AVOD) and subscription video on demand (SVOD). The AVOD model accounted for the major chunk of the total market revenue (~62.67%) for video OTT players in FY 2021, which is expected to continue as the leading segment till FY 2026. The SVOD model is growing faster and will contribute more to the total video OTT revenue. The OTT platforms can also be segmented on the basis of the market share of the major players. Hotstar has the maximum share in the video OTT market and Gaana leads in the audio OTT market.

COVID-19 impact analysis:
Amid the nationwide lockdown because of the ongoing coronavirus (COVID-19) pandemic, content consumption and subscriber count on OTT platforms surged. With an increase in viewers’ appetite for new content, OTTs are having to step up their efforts and deliver quality entertainment.
In 2020, the total domestic OTT consumption increased from 181 billion minutes to 204 billion minutes. With an increase in customer acquisition during the pandemic, OTT players are compelled to innovate and offer seamless experience in order to cater to the need for content. Some of the key strategies are collaborations with telecoms and the growth of the device ecosystem.

OTT (Over-the-Top) Market in India 2020

The post OTT (Over-the-Top) Market in India 2021 first appeared on CRI Report.

The post Petrochemical Market in India 2021 first appeared on CRI Report.

Medical supplies are protective devices used against pathogens and diseases to protect healthcare personnel. Disposable medical supplies are worn during surgical operations, medical testing, and chemotherapy to avoid cross-contamination between doctors and nurses, and doctors and patients. Disposable medical supplies are an important part of the infection control strategy and FDA controls their use as medical equipment reserved for Class I use.
Market Highlights

China Medical Epidemic Prevention Products Supplier List Market size was registered at USD XX billion in 2019, and is estimated to reach USD XX billion by 2030, registering a CAGR of XX% from 2020 to 2030. During surgery and general patient care, low-cost medical supplies replace high-value added single-use items which will drive the growth of the Medical Supplies industry. Increasing demand for medical supplies, particularly gloves and face masks, is the major fueling factor for the Medical Supplies market due to increased awareness among workers regarding hygiene and safety. The key demand drivers in this sector are increasing geriatric population, increasing number of patients with chronic diseases such as cardiovascular, renal, diabetes, hypertension and others.
China Medical Epidemic Prevention Products Supplier List Market: Segments

China Medical Epidemic Prevention Products Supplier List Market is segmented on the basis of type, application, end user and region.

By Type (in %), China Medical Epidemic Prevention Products Supplier List Market, 2019
The Intubation & Ventilation Supplies segment is anticipated to register XX% of the market share during the forecasted period.
By type the market can be segmented into Diagnostic Supplies, Infusion & Injectable Supplies, Intubation & Ventilation Supplies, Disinfectants, Personal Protective Equipment, Sterilization Consumables, Wound Care Consumables, Dialysis Consumables, Radiology Consumables, Catheters, Sleep Apnea Consumables and Other Medical Supplies. During the forecast period the segment of intubation and ventilation consumables is expected to rise at the highest CAGR. This is due to the increased occurrence of respiratory disorders, such as asthma and COPD, as well as the growing prevalence of COVID-19 in the region.
China Medical Epidemic Prevention Products Supplier List Market Dynamics:

Increasing geriatric population and low-cost material cost to increase market growth
The key demand drivers in this sector are increasing geriatric population, increasing number of patients with chronic diseases such as cardiovascular, renal, diabetes, hypertension and others. Development would contribute to safety-enhanced tools for the minimally invasive delivery of parenteral medications, inhalation therapies, and IV and dialysis solutions.
Low financial resources to hinder the market growth in China
Healthcare providers have low financial resources, especially in developing countries such as China, to invest in such expensive sophisticated technologies.
China Medical Epidemic Prevention Products Supplier List Market: Regions

In terms of value and volume, China accounted for XX% of total market volume share in 2019
Healthcare reform has been one of the primary issues on the Chinese policy agenda. Due to the rise in healthcare costs, more than 10 percent of the income is spent on healthcare, which is higher than that spent on education and transportation. The rise in healthcare costs will likely result from the rising medication prices. Rapid consolidation between medium and large players in the sector is expected as the Chinese government has promoted industry consolidation in an attempt to regulate the industry and better control drug pricing. There are about 4500 pharmaceutical companies in China, most of which are small players in restricted local market presence.
China Medical Epidemic Prevention Products Supplier List Market: Competitive landscape

Some factors that improve the role in the market of the key players within the China Medical Epidemic Prevention Products Supplier List Market have been the improvement in healthcare facilities among key players and availability of favorable reimbursement policies and FDA approvals in developed regions coupled with the growth in preference for minimally invasive procedures.
China Medical Epidemic Prevention Products Supplier List Market: Key players

• Sinopharm Group
o Company Overview
o Business Strategy
o Key Product Offerings
o Financial Performance
o Key Performance Indicators
o Risk Analysis
o Recent Development
o Regional Presence
o SWOT Analysis
• Shanghai Pharmaceuticals
• Jiangsu Hengrui Medicine
• CEO: Sun Piaoyang
• Guangzhou Baiyunshan Pharmaceutical
• China Meheco
• Huadong Medicine
• Yunnan Baiyao
• Shanghai Fosun Pharmaceutical
• Other prominent players
China Medical Epidemic Prevention Products Supplier List Market report also contains analysis on:

• China Medical Epidemic Prevention Products Supplier List Market segments: –

• By Type:

o Diagnostic Supplies
o Infusion & Injectable Supplies
o Intubation & Ventilation Supplies
o Disinfectants
o Personal Protective Equipment
o Sterilization Consumables
o Wound Care Consumables
o Dialysis Consumables
o Radiology Consumables
o Catheters
o Sleep Apnea Consumables
o Other Medical Supplies

• By Application:

o Urology
o Wound Care
o Radiology
o Respiratory
o Infection Control
o Cardiology
o IVD
o Other Applications

• By End User:
o hospitals
o physician clinics
o other

• China Medical Epidemic Prevention Products Supplier List Market dynamics
• China Medical Epidemic Prevention Products Supplier List Market size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies Involved in the Market
• Value Chain of the Market
• Market Drivers and Restraints

The post China Medical Epidemic Prevention Products Supplier List Market Outlook 2030: Industry Insights & Opportunity Evaluation, 2019-2030 first appeared on CRI Report.

By Type (Monofocal Intraocular Lens and Premium Intraocular Lens.); By Material (Polymethylmethacrylate (PMMA) and Foldable.); By End User (Hospitals and Ambulatory Surgery Centers, Specialty Clinics and Academic and Research Institutes) and Region –Analysis of Market Size, Share and Trends for 2014 – 2019 and Forecasts to 2030.

Product Overview

Intraocular lens (IOL) is an eye-implanted lens used for the treatment of cataracts or myopia. The most prevalent form of IOL is pseudophakic IOL. These are inserted during cataract surgery, following removal of the blurry crystalline lens. The pseudophakic IOL replaces the original crystalline lens and provides the light-focusing feature which the crystalline lens originally undertook.

The second type of IOL, more generally referred to as a phakic intraocular lens (PIOL), is a lens that is mounted above the original natural lens and used in refractive surgery to modify the optical capacity of the eye as a treatment for myopia or near sight.

China Intraocular Lens Market Highlights

China Intraocular Lens Market size was registered at USD XX billion in 2019, and is estimated to reach USD XX billion by 2030, registering a CAGR of XX% from 2020 to 2030. Growth in geriatric population vulnerable to ocular conditions, rise in cataract prevalence and increase in government initiatives to reduce avoidable blindness are expected to drive growth in the global market for intraocular lenses.

Furthermore, the rise in the adoption of premium lens due to its advantages such as improved visual clarity and reduced astigmatism supports market development.

China Intraocular Lens Market: Segments

China Intraocular Lens Market is segmented on the basis of type, material, end user and region.

By Type (in %), China Intraocular Lens Market, 2019
The Intraocular Premium lens segment is anticipated to register XX% of the market share during the forecasted period

By Type the market can be segmented into Monofocal Intraocular Lens and Premium Intraocular Lens.
Intraocular Premium lenses include multifocal, toric, and accommodative lenses. Advanced advantages provided by premium lenses include multifocal aperture, better visibility, and removal of the need for glass after cataract, and greater accuracy. These features, despite being comparatively more costly, are increasing their acceptance globally.

China Intraocular Lens Market Dynamics:

Government initiatives along with increased adoption to increase market growth

Growth in geriatric population vulnerable to ocular conditions, rise in cataract prevalence and increase in government initiatives to reduce avoidable blindness are expected to drive growth in the global market for intraocular lenses.

High costs and post-surgical complications to hinder the market growth in China

The demand for intraocular lenses is affected by high costs associated with cataract care and inadequate coverage of both conventional and advanced procedures. In addition, post-surgical complications also threaten to constrain development.

China Intraocular Lens Market: Regions

In terms of value and volume, China accounted for XX% of total market volume share in 2019
With the increase in the geriatric population along with diabetic population in developed countries, cataract and other retinal procedures are more commonly accepted, thus increasing the demand for intraocular lenses in China.

In addition, policy initiatives to develop and market cost-effective treatment options, and joint efforts by private and government agencies to create eye care facilities are driving market growth in the region.

China Intraocular Lens Market: Competitive landscape

Some factors that improve the role in the market of the key players within the China Intraocular Lens Market have been the improvement in healthcare facilities among key players and availability of favorable reimbursement policies and FDA approvals in developing regions.

China Intraocular Lens Market: Key players

• Alcon
o Company Overview
o Business Strategy
o Key Product Offerings
o Financial Performance
o Key Performance Indicators
o Risk Analysis
o Recent Development
o Regional Presence
o SWOT Analysis

• Bausch & Lomb
• CARL Zeiss
• HumanOptics
• Rayner
• STAAR Surgical
• Haohai Biological Technology
• Eyebright Medical
• Wuxi Vision Pro Ltd
• Other prominent players

China Intraocular Lens Market report also contains analysis on:

China Intraocular Lens Market segments:

• By Type:

o Monofocal Intraocular Lens
o Premium Intraocular Lens

• By Material:

o Polymethylmethacrylate (PMMA)
o Foldable

• By End User
o Hospitals and Ambulatory Surgery Centers
o Specialty Clinics
o Academic and Research Institutes

• China Intraocular Lens Market dynamics
• China Intraocular Lens Market size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies Involved in the Market
• Value Chain of the Market
• Market Drivers and Restraints

Related  reports:

Global Contact and Intraocular Lenses Market Research Report—Forecast till 2025

The post China Intraocular Lens (IOL) Market Outlook 2030: Industry Insights & Opportunity Evaluation, 2019-2030 first appeared on CRI Report.

China Glass Lined Reactor Market size was registered at USD XX billion in 2019, and is estimated to reach USD XX billion by 2030, registering a CAGR of XX% from 2020 to 2030. Foreign firms have more sophisticated facilities, high research and development capabilities, and the technological level is in the lead in the market of glass lined reactors. But the manufacturing costs of foreign companies are relatively high compared to Chinese companies, the operating costs have a competitive disadvantage, as the production technology of the Chinese Glass Lined Reactor continues to develop, their share in the international market is grows.
China Glass Lined Reactor Market: Segments
China Glass Lined Reactor Market is segmented on the basis of type, application and region.
By Type (in %), China Glass Lined Reactor Market, 2019
The AE type segment is anticipated to register XX% of the market share during the forecasted period.
By type the market can be segmented into AE type, BE type and CE type. The AE type reactor consists of a vessel and a cover, and the reactor ranges from 63 liter to 6300 liter and thus can be used in various applications increasing the growth of the segment.
China Glass Lined Reactor Market Dynamics:

Low manufacturing costs and advanced technology to increase market growth

Foreign firms have more sophisticated facilities, high research and development capabilities, and the technological level is in the lead in the market of glass lined reactors. But the manufacturing costs of foreign companies are relatively high compared to Chinese companies, the operating costs have a competitive disadvantage, as the production technology of the Chinese Glass Lined Reactor continues to develop, their share in the international market grows.
Intellectual property rights and capital costs to hinder the market growth in China

Long – term productivity obstacles make it difficult to enter the market. Such obstacles include the expense of product production, capital costs, intellectual property rights, regulatory requirements and unfair competition strategies used by transfers.

China Glass Lined Reactor Market: Regions

In terms of value and volume, China accounted for XX% of total market volume share in 2019
Glass Lined Reactor industry is typically more advanced in the international industrial developing countries, with the largest companies in the world primarily located in China. Meanwhile, foreign firms have more sophisticated facilities, high research and development capabilities, and the technological level is in the lead. But the manufacturing costs of foreign companies are relatively high compared to Chinese companies, the operating costs have a competitive disadvantage, as the production technology of the Chinese Glass Lined Reactor continues to develop, their share in the international market is growing, and competition on the international market is slowly increasing.
China Glass Lined Reactor Market: Competitive landscape

Some factors that improve the role in the market of the key players within the China Glass Lined Reactor Market have been the improvement in healthcare facilities among key players and availability of favorable reimbursement policies and FDA approvals in developing regions.
China Glass Lined Reactor Market: Key players

• Zibo Huaxing Chemical Equipment
o Company Overview
o Business Strategy
o Key Product Offerings
o Financial Performance
o Key Performance Indicators
o Risk Analysis
o Recent Development
o Regional Presence
o SWOT Analysis
• Zibo Taiji Glass Lined Equipment
• De Dietrich Process Systems
• Jiangsu Liyang Yunlong Equipment Manufacting
• Jiangsu Yangyang Chemical Equipment’s Manufacture
• Huanghe Chemical Equipment
• Jiangsu Gongtang Chemical Equipment’s
• Zibo Zhongsheng Machinery
• Shandong Zhuoxin Industrial Enamel
• Other prominent players
China Glass Lined Reactor Market report also contains analysis on:

• China Glass Lined Reactor Market segments:-

• By Type:

o AE type
o BE type
o CE type

• By Application:

o Pharmaceutical
o Petrochemical
o Food industries
o Other

• China Glass Lined Reactor Market dynamics
• China Glass Lined Reactor Market size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies Involved in the Market
• Value Chain of the Market
• Market Drivers and Restraints

The post China Glass Lined Reactor Market Outlook 2030: Industry Insights & Opportunity Evaluation, 2019-2030 first appeared on CRI Report.

Endoscopy enables both surgeries on more vulnerable patients, especially the elderly, and treatment of more complicated diseases like cancer. Certain advantages of endoscopy include lower post-operative pain and infection complications, faster recovery, stronger anesthesia, and shorter hospital stay. Surgery, interventional radiology, and advanced endoscopy have also evolved minimally invasive procedures for the successful treatment of a range of diseases to have a significant impact on the postoperative outcomes of patients.
Market Highlights
China Endoscope Market size was registered at USD XX billion in 2019, and is estimated to reach USD XX billion by 2030, registering a CAGR of XX% from 2020 to 2030. Endoscopy procedures are less invasive and save pre- and post-operative care costs as well as the length of stay at hospitals. These services are also largely provided in selected countries by health insurance companies.
China Endoscope Market: Segments
China Endoscope Market is segmented on the basis of product, application and region.
By Product (in %), China Endoscope Market, 2019
The endoscopy device segment is anticipated to register XX% of the market share during the forecasted period.
By product the market can be segmented into endoscopy devices, visualization & documentation systems, mechanical endoscopy equipment, accessories, and other endoscopy equipment. The endoscopy instruments are widely used in the diagnosis and treatment of various diseases. Increasing geriatric population coupled with increasing gastrointestinal tract-related disorders are also prime reasons for endoscopy tools finding tremendous applications. In addition, increasing knowledge of endoscopic tools, preference for minimally invasive endoscopic procedures, lower postoperative complications and a quicker recovery time are only a few of the several factors that render endoscopic tools usage satisfying over the forecast period.

China Endoscope Market Dynamics:

Use in treatments and diagnosis and rising target health incidents to increase market growth

Endoscopy procedures are less invasive and save pre- and post-operative care costs as well as the length of stay at hospitals. These services are also largely provided in selected countries by health insurance companies. Such factors also contribute to an increased preference among patients and physicians for endoscopy procedures.
Low financial resources and maintaining equipments for endoscopy to hinder the market growth in China
Healthcare providers have low financial resources, especially in developing countries such as China, to invest in such expensive sophisticated technologies. In addition, the personnel will be qualified to manage and operate endoscopy systems and equipment effectively. Maintaining endoscopy equipment is important, as improperly reprocessed endoscopes can lead to cross-contamination and potentially expose patients to infection.
China Endoscope Market: Regions

In terms of value and volume, China accounted for XX% of total market volume share in 2019
The growing awareness of minimally invasive procedures among the Chinese population and the increasing prevalence of chronic diseases across the country are boosting demand for endoscopic devices. Capsule endoscopy is an accurate, automatic, quick, and painless form of digestive tract mucosal imaging. This has various potential applications and a growing role in pathological digestive analysis. It is expected that the capsule endoscopy market in China will be guided by the technical developments embraced by medical professionals in China, and a growing number of new players expanding the industry in the Chinese market. The launch of technologically advanced devices, such as Wi-Fi-enabled small bowel capsules, with longer battery life, is expected to further boost the market for endoscopy capsules.
The region segment can be further divided into five major types including North China, South China, East China and West China.
China Endoscope Market: Competitive landscape

Some factors that improve the role in the market of the key players within the China Endoscope Market have been the improvement in healthcare facilities among key players and availability of favorable reimbursement policies and FDA approvals in developed regions coupled with the growth in preference for minimally invasive procedures.
China Endoscope Market: Key players

• Cook Medical
o Company Overview
o Business Strategy
o Key Product Offerings
o Financial Performance
o Key Performance Indicators
o Risk Analysis
o Recent Development
o Regional Presence
o SWOT Analysis
• Boston Scientific Corporation
• Conmed Corporation
• Richard Wolf GmbH
• Johnson and Johnson
• Fujifilm Holdings
• Medtronic PLC
• Olympus Corporation
• Other prominent players
China Endoscope Market report also contains analysis on:
China Endoscope Market segments: –

• By Product:
o endoscopy devices
o visualization and documentation systems
o mechanical endoscopy equipment
o accessories
o other endoscopy equipment

• By Application:
o Bronchoscopy
o arthroscopy
o laparoscopy
o urologyendoscopy
o neuro-endoscopy
o gastrointestinal endoscopy
o gynecology endoscopy
o ENT endoscopy
o others

• China Endoscope Market dynamics
• China Endoscope Market size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies Involved in the Market
• Value Chain of the Market
• Market Drivers and Restraints

The post China Endoscope Market Outlook 2030: Industry Insights & Opportunity Evaluation, 2019-2030 first appeared on CRI Report.